2VRR image
Entry Detail
PDB ID:
2VRR
Title:
Structure of SUMO modified Ubc9
Biological Source:
Source Organism:
PDB Version:
Deposition Date:
2008-04-13
Release Date:
2008-08-19
Method Details:
Experimental Method:
Resolution:
2.22 Å
R-Value Free:
0.25
R-Value Work:
0.17
R-Value Observed:
0.17
Space Group:
P 21 21 21
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:SUMO-CONJUGATING ENZYME UBC9
Chain IDs:A
Chain Length:158
Number of Molecules:1
Biological Source:MUS MUSCULUS
Polymer Type:polypeptide(L)
Description:SMALL UBIQUITIN-RELATED MODIFIER 1
Chain IDs:B
Chain Length:79
Number of Molecules:1
Biological Source:HOMO SAPIENS
Primary Citation
Ubc9 sumoylation regulates SUMO target discrimination.
Mol. Cell 31 371 382 (2008)
PMID: 18691969 DOI: 10.1016/j.molcel.2008.05.022

Abstact

Posttranslational modification with small ubiquitin-related modifier, SUMO, is a widespread mechanism for rapid and reversible changes in protein function. Considering the large number of known targets, the number of enzymes involved in modification seems surprisingly low: a single E1, a single E2, and a few distinct E3 ligases. Here we show that autosumoylation of the mammalian E2-conjugating enzyme Ubc9 at Lys14 regulates target discrimination. While not altering its activity toward HDAC4, E2-25K, PML, or TDG, sumoylation of Ubc9 impairs its activity on RanGAP1 and strongly activates sumoylation of the transcriptional regulator Sp100. Enhancement depends on a SUMO-interacting motif (SIM) in Sp100 that creates an additional interface with the SUMO conjugated to the E2, a mechanism distinct from Ubc9 approximately SUMO thioester recruitment. The crystal structure of sumoylated Ubc9 demonstrates how the newly created binding interface can provide a gain in affinity otherwise provided by E3 ligases.

Legend

Protein

Chemical

Disease

Primary Citation of related structures